STOCK ALARM
PRO
SA
PRO
News
Screener
Rankings
Themes
Alerts
More
⌘
K
⌘
J
Pro
Sign In
Free Account
Themes
Abbott Laboratories
ABT
NYSE
Loading
Overview
Intelligence
Charts
News
Fundamentals
Financials
Analysis
More
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Income
Balance
Cash Flow
Annual
Quarterly
3Y
5Y
10Y
All
Revenue
$44B
↑6%
Gross Profit
$25B
↑15%
Operating Income
$8B
↑18%
Net Income
$7B
↓51%
EBITDA
$12B
↑7%
EPS Diluted
3.7
Cost of Revenue
$20B
Gross Margin %
55.5%
R&D Expenses
$3B
SG&A Expenses
$12B
Operating Expenses
$17B
Operating Margin %
18.2%
Interest Expense
$341M
Income Before Tax
$8B
Income Tax Expense
$2B
Net Margin %
14.7%
EPS
3.7
Shares Out (Diluted)
1.7B
Shares Out (Basic)
1.7B
Total Costs & Expenses
$36B
Interest Income
$230M
EBITDA Margin %
26.1%
Pre-Tax Margin %
19.1%
Other Income/Expenses
$418M
Revenue CAGR (5Y)
+5.1%
Margin Trend
stable
Free Cash Flow
$7.4B
Profitability
Profitable
Metric
Dec 21
Dec 22
Dec 23
Dec 24
Dec 25
Revenue
43,075
43,653
↑1.3%
40,109
↓8.1%
41,950
↑4.6%
44,328
↑5.7%
Gross Profit
23,214
22,323
↓3.8%
20,037
↓10.2%
21,325
↑6.4%
24,607
↑15.4%
Operating Income
9,200
8,362
↓9.1%
6,435
↓23.0%
6,825
↑6.1%
8,048
↑17.9%
Net Income
7,071
6,933
↓2.0%
5,723
↓17.5%
13,402
↑134.2%
6,524
↓51.3%
EBITDA
12,159
11,888
↓2.2%
10,605
↓10.8%
10,834
↑2.2%
11,553
↑6.6%
EPS Diluted
3.94
3.91
↓0.8%
3.27
↓16.4%
7.64
↑133.6%
3.72
↓51.3%
Show all metrics
← Newer
1 / 2
Older →
Values in millions except EPS · Ratios shown as percentages